Synapse - Works

Results (21)

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

Journal Article

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

Journal Article

Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation

Journal Article

Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Journal Article

Janjigian, Y. Y.; Azzoli, C. G.; Krug, L. M.; Pereira, L. K.; Rizvi, N. A.; Pietanza, M. C.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

Journal Article

Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development

Journal Article

Zhao, B.; Oxnard, G. R.; Moskowitz, C. S.; Kris, M. G.; Pao, W.; Guo, P.; Rusch, V.; Ladanyi, M.; Rizvi, N. A.; Schwartz, L. H.
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report

Journal Article

Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Lung cancer in never smokers: Molecular profiles and therapeutic implications

Journal Article

Rudin, C. M.; Avila-Tang, E.; Harris, C. C.; Herman, J. G.; Hirsch, F. R.; Pao, W.; Schwartz, A. G.; Vahakangas, K. H.; Samet, J. M.
Clinical Cancer Research (2009)

Fulltext@MSK | Save

Integration of molecular profiling into the lung cancer clinic

Journal Article

Pao, W.; Kris, M. G.; Iafrate, A. J.; Ladanyi, M.; Jänne, P. A.; Wistuba, I. I.; Miake-Lye, R.; Herbst, R. S.; Carbone, D. P.; Johnson, B. E.; more...
Clinical Cancer Research (2009)

Fulltext@MSK | Save

Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas

Journal Article

Girard, N.; Shen, R.; Guo, T.; Zakowski, M. F.; Heguy, A.; Riely, G. J.; Huang, J.; Lau, C.; Lash, A. E.; Ladanyi, M.; more...
Clinical Cancer Research (2009)

Fulltext@MSK | Save